Gum disease breakthrough? blood concentrate shows promise in small trial
NCT ID NCT07375004
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding injectable Platelet-Rich Fibrin (i-PRF), a natural concentrate from a patient's own blood, to standard deep cleaning improves gum disease outcomes. In 13 adults with moderate to severe periodontitis, one side of the mouth received the combined treatment and the other side standard cleaning alone. Researchers measured pocket depth, gum attachment, and bacterial levels over 3 months to see if i-PRF provides extra benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
13 people
The number who actually took part.
- Started
-
Nov 2025
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult subjects aged 30 years and above. * No history of systemic diseases (e.g., diabetes mellitus). * Not currently under active periodontal therapy or joining other trial in the last 3 months. * Diagnosis with Stage II or III Periodontitis. * presence of interdental CAL affecting ≥2 non adjacent teeth or if CAL at buccal/lingual aspects associated with PPD \>4mm at ≥2 teeth. Exclusion Criteria: * Smokers or alcohol users. * Patients consuming antibiotics or anticoagulants. * Regular users of non-steroidal anti-inflammatory drugs. * Receipt of periodontal treatment within 3 months prior to the study. * Any bleeding or clotting disorders. * Teeth with Grade II or Grade III furcation involvement. * Pregnant or breastfeeding mothers. * Patients unwilling to participate.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alveolar bone loss are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mustansiriyah University, College of Dentistry.
Baghdad, Iraq
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a pill replace an IV for gum surgery pain relief?
- Stem cell signals could help rebuild jawbone for dental implants
- Can everyday supplements boost gum disease therapy?
- Can pulling a loose tooth and putting it back save it?
- Gum fluid proteins eyed as link between smoking and periodontitis
- Gum fluid holds clues to Behçet's disease puzzle